Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Nasdaq

Recap: Minerva Neurosciences Q1 Earnings

Minerva Neurosciences (NASDAQ:NERV) reported its Q1 earnings results on Wednesday, May 4, 2022 at 07:30 AM. Here's what investors need to know about the announcement.

Benzinga

What 6 Analyst Ratings Have To Say About Zebra Technologies

Zebra Technologies (NASDAQ:ZBRA) has observed the following analyst ratings within the last quarter:

Benzinga

How Is The Market Feeling About Google?

Alphabet's (NASDAQ:GOOG) short percent of float has fallen 13.56% since its last report. The company recently reported that it has 1.40 million shares sold short, which is 0.51% of all regular shares that are available for trading.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Carlyle Group: Q1 Earnings Insights

Carlyle Group (NASDAQ:CG) reported its Q1 earnings results on Thursday, April 28, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

Benzinga

Analyst Ratings for Sprout Social

Within the last quarter, Sprout Social (NASDAQ:SPT) has observed the following analyst ratings:

Benzinga

What 6 Analyst Ratings Have To Say About Freshworks

Analysts have provided the following ratings for Freshworks (NASDAQ:FRSH) within the last quarter:

Benzinga

4 Analysts Have This to Say About AtriCure

Over the past 3 months, 4 analysts have published their opinion on AtriCure (NASDAQ:ATRC) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

10 Analysts Have This to Say About Marqeta

Within the last quarter, Marqeta (NASDAQ:MQ) has observed the following analyst ratings:

Benzinga

Recap: eXp World Holdings Q1 Earnings

eXp World Holdings (NASDAQ:EXPI) reported its Q1 earnings results on Wednesday, May 4, 2022 at 08:30 AM. Here's what investors need to know about the announcement.

Benzinga

Recap: Oncorus Q1 Earnings

Oncorus (NASDAQ:ONCR) reported its Q1 earnings results on Wednesday, May 4, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Benzinga

What's Going On With Starbucks Shares Today?

Starbucks Corporation (NASDAQ: SBUX) shares are trading higher by 6.96% to $79.50 during Wednesday’s pre-market session. The company reported better-than-expected second-quarter sales during Tuesday’s after-hours session.

Benzinga

FDA Accepts AstraZeneca's sBLA for Imfinzi (durvalumab) in biliary tract cancer (BTC) with Priority Review

The U.S. Food and Drug Administration (FDA) has accepted AstraZeneca's (NASDAQ: AZN) supplemental Biologics License Application (sBLA) for Imfinzi (durvalumab), in combination with standard-of-care chemotherapy and granted Priority Review for patients with locally advanced or metastatic biliary tract cancer (BTC).

Benzinga

Why Airbnb Stock Is Moving Higher

Airbnb Inc (NASDAQ: ABNB) shares are trading higher Wednesday after the company reported better-than-expected financial results and issued guidance above analyst estimates.

Benzinga

Berry: Q1 Earnings Insights

Berry (bry) (NASDAQ:BRY) reported its Q1 earnings results on Wednesday, May 4, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Recap: International Money Q1 Earnings

International Money (NASDAQ:IMXI) reported its Q1 earnings results on Wednesday, May 4, 2022 at 06:30 AM. Here's what investors need to know about the announcement.

Benzinga

Why Lumentum Shares Are Trading Higher Today

Lumentum Holdings Inc (NASDAQ:LITE) reported third-quarter FY22 revenue of $395.4 million, down 5.7% year-on-year, in line with the consensus. Optical Communications revenue declined 11.3% Y/Y to $344.2 million, and Lasers revenue rose 62% Y/Y to $51.2 million. Margins: The non-GAAP gross margin contracted 40 bps to 49.5%. The non-GAAP operating margin compressed 140 bps…

Benzinga

Why This AMD Analyst Is Lowering Price Target After Chipmaker's Stellar Q1

Advanced Micro Devices, Inc. (NASDAQ: NASDAQ) reported forecast-beating quarterly results on Tuesday and raised its full-year revenue guidance.

Benzinga

Morphic Holding: Q1 Earnings Insights

Morphic Holding (NASDAQ:MORF) reported its Q1 earnings results on Wednesday, May 4, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Tecnoglass: Q1 Earnings Insights

Tecnoglass (NASDAQ:TGLS) reported its Q1 earnings results on Wednesday, May 4, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Benzinga

Recap: Ionis Pharmaceuticals Q1 Earnings

Ionis Pharmaceuticals (NASDAQ:IONS) reported its Q1 earnings results on Wednesday, May 4, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

Benzinga

Sinclair Broadcast Group: Q1 Earnings Insights

Sinclair Broadcast Group (NASDAQ:SBGI) reported its Q1 earnings results on Wednesday, May 4, 2022 at 07:30 AM. Here's what investors need to know about the announcement. Earnings Sinclair Broadcast Group posted an EPS of $0.37.

Benzinga

Insiders Buy More Than $50M Of 3 Penny Stocks

Gold futures traded lower on Wednesday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Benzinga

The Daily Biotech Pulse: Kezar Life's Lead Asset Fails, Brickell Biotech Offloads Late-Stage Asset, Connect Biopharma Ulcerative Colitis Trial Disappoints

Here's a roundup of top developments in the biotech space over the last 24 hours.

Benzinga

FDA Grants Fast Track designation To Aptose Biosciences for HM43239 in Relapsed/Refractory AML Patients and FLT3 Mutation

Aptose Biosciences Inc. (NASDAQ: APTO) announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to HM43239, an oral, myeloid kinome inhibitor, for the treatment of patients with relapsed or refractory (R/R) acute myeloid leukemia (AML) with FLT3 mutation.

Benzinga

Recap: BlackRock TCP Capital Q1 Earnings

BlackRock TCP Capital (NASDAQ:TCPC) reported its Q1 earnings results on Wednesday, May 4, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

1 … 579 580 581 582

People

John Vinh

49 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Starbucks Corporation

73 stories

Carlyle Group

53 stories

Sinclair Broadcast Group

Read news from The Economist, FT, and more,
with one subscription

Topics

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.